Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.15 - $1.48 $767 - $987
-667 Reduced 17.64%
3,115 $3,000
Q4 2023

Feb 13, 2024

SELL
$1.22 - $1.62 $1,727 - $2,293
-1,416 Reduced 27.24%
3,782 $5,000
Q3 2023

Nov 14, 2023

SELL
$0.98 - $1.62 $6,621 - $10,946
-6,757 Reduced 56.52%
5,198 $8,000
Q2 2023

Aug 14, 2023

BUY
$0.58 - $1.31 $3,248 - $7,336
5,600 Added 88.12%
11,955 $11,000
Q1 2023

May 09, 2023

SELL
$0.76 - $1.82 $6,675 - $15,985
-8,783 Reduced 58.02%
6,355 $6,000
Q4 2022

Feb 10, 2023

BUY
$0.64 - $0.91 $2,744 - $3,902
4,289 Added 39.53%
15,138 $11,000
Q3 2022

Nov 10, 2022

BUY
$0.68 - $1.11 $314 - $512
462 Added 4.45%
10,849 $7,000
Q2 2022

Aug 15, 2022

SELL
$0.75 - $1.33 $2,456 - $4,355
-3,275 Reduced 23.97%
10,387 $10,000
Q1 2022

May 12, 2022

SELL
$1.29 - $4.04 $16,901 - $52,932
-13,102 Reduced 48.95%
13,662 $18,000
Q4 2021

Feb 14, 2022

BUY
$3.45 - $6.05 $68,686 - $120,449
19,909 Added 290.43%
26,764 $103,000
Q3 2021

Nov 15, 2021

BUY
$5.53 - $9.28 $21,052 - $35,328
3,807 Added 124.9%
6,855 $38,000
Q2 2021

Aug 16, 2021

BUY
$7.84 - $12.6 $11,634 - $18,698
1,484 Added 94.88%
3,048 $27,000
Q1 2021

May 17, 2021

SELL
$10.54 - $19.3 $3,309 - $6,060
-314 Reduced 16.72%
1,564 $20,000
Q4 2020

Feb 16, 2021

SELL
$12.79 - $17.1 $2,314 - $3,095
-181 Reduced 8.79%
1,878 $26,000
Q3 2020

Nov 16, 2020

SELL
$12.99 - $19.41 $47,556 - $71,060
-3,661 Reduced 64.0%
2,059 $26,000
Q2 2020

Aug 13, 2020

BUY
$12.19 - $22.96 $61,035 - $114,960
5,007 Added 702.24%
5,720 $100,000
Q1 2020

May 15, 2020

SELL
$10.08 - $27.21 $23,143 - $62,474
-2,296 Reduced 76.3%
713 $12,000
Q4 2019

Feb 07, 2020

BUY
$13.05 - $21.88 $13,480 - $22,602
1,033 Added 52.28%
3,009 $61,000
Q3 2019

Nov 05, 2019

BUY
$14.12 - $23.44 $27,901 - $46,317
1,976 New
1,976 $28,000
Q1 2019

May 14, 2019

SELL
$12.46 - $22.05 $26,128 - $46,238
-2,097 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$15.43 - $32.7 $32,356 - $68,571
2,097 New
2,097 $35,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.